Sino Biological Inc. (SHE: 301047), a leading provider of biological research reagents and technical contract research services based in China, has entered into a definitive Share Purchase Agreement to acquire SignalChem Biotech Inc. (SCB), a Vancouver, Canada-based manufacturer of specialized bioactive enzymes. The transaction values 100% of SCB’s shares at approximately USD 48 million.
SignalChem is renowned for setting industry standards in the manufacturing of bioactive enzymes, including kinases, proteases, phosphatases, and epigenetic enzymes. The acquisition is expected to bolster Sino Bio’s product portfolio and strengthen its position in the global biological research market.- Flcube.com
